Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 29, 2024PharmaceuticsOpen Access

Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

EWEun-Jeong WonKorea Research Institute of Bioscience and BiotechnologyMLMyung Chul LeeBrigham and Women's HospitalELEui‐Kyung LeeSungkyunkwan University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Won et al. (2024) studied this question.

synapsesocial.com/papers/68e5a5f5b6db6435875402echttps://doi.org/10.3390/pharmaceutics16091142
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Defects in Cell Growth Regulation by C18:0-Ceramide and Longevity Assurance Gene 1 in Human Head and Neck Squamous Cell Carcinomas2004 · 228 citations
  2. 2Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy2017 · 217 citations
  3. 3Immunogenic Cell Death in Cancer Therapy2012 · 3,335 citations
  4. 4The effect of altered sphingolipid acyl chain length on various disease models2015 · 68 citations
  5. 5Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells2018 · 113 citations